AeroLeads people directory · profile
Prashant Thakkar, Ph.D. Email & Phone Number
Associate Director, Medical Intelligence, Global Oncology Medical Affairs
at
Daiichi Sankyo
LinkedIn matched
✓ Verified Jun 2026
3 data sources
Profile completeness 86%
Current company
Role
Associate Director, Medical Intelligence, Global Oncology Medical Affairs
Location
New York City Metropolitan Area, United States, United States
Who is Prashant Thakkar, Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Prashant Thakkar, Ph.D. is listed as Associate Director, Medical Intelligence, Global Oncology Medical Affairs at Daiichi Sankyo, based in New York City Metropolitan Area, United States, United States. AeroLeads shows a matched LinkedIn profile for Prashant Thakkar, Ph.D..
Prashant Thakkar, Ph.D. previously worked as Associate Director, Commercial Analytics at Agenus and Senior Manager Corporate Development at Agenus. Prashant Thakkar, Ph.D. holds Doctor Of Philosophy (Ph.D.), Microbiology And Immunology from Virginia Commonwealth University School Of Medicine.
Company email context
Email format at Daiichi Sankyo
This section adds company-level context without repeating Prashant Thakkar, Ph.D.'s masked contact details.
Daiichi Sankyo
Review company-level records connected to Prashant Thakkar, Ph.D. before choosing the right outreach path.
Profile bio
About Prashant Thakkar, Ph.D.
Postdoctoral fellow with experience in clinical and translational oncology research; ability to work in with multiple interdisciplinary teams; creative and flexible team player with strong writing and presentation skills and high attention to detail.
Current workplace
Prashant Thakkar, Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
11 roles
Prashant Thakkar, Ph.D. work experience
A career timeline built from the work history available for this profile.
Associate Director, Commercial Analytics
Current
Oct 2024 - Present
Senior Manager Corporate Development
- Forecasting: Co-managed forecasts for an asset with >$2B in peak sales across 3 indications to support BD discussions.
- Market Research: Engaged external research firm for 20 KOL interviews, and incorporated insights to enhance commercial forecasts and market assessment.
- Business Development: Conducted 6 competitive landscape assessments to support materials for partnering and strategic financing discussion.
- Led discussions with multiple biotechs to evaluate clinical collaboration opportunities for Botensilimab (anti-CTLA-4).
- New Product Planning: Led indication prioritization for Phase 1 CD137 asset, integrating cross-functional insights to streamline clinical development plans for maximum value.
- Alliance Management: Alliance lead for Betta Pharma collaboration (balstilimab and zalifrelimab (anti-CTLA-4)) in China.
Jul 2023 - Oct 2024
Manager, Corporate Development
Feb 2023 - Jul 2023
Manager, Oncology Strategy And Competitive Analysis
- Led strategic analyses and competitive intelligence for 7 clinical-stage assets including lead-asset, botensilimab across 10 different indications.
- Covered 25+ major medical/scientific conferences (ASCO, SITC, ESMO etc.) and led debriefs and/or seminars on findings.
- Monitored trends and opportunities in immune-oncology space and covered 50+ competitor earnings calls to provide real-time, actionable insights.
- Led bi-weekly CI meetings to keep senior leadership informed on essential competitive intelligence information, shaping development go/no-go decisions.
- Conducted comprehensive training for 10+ MSLs, ensuring proficiency in botensilimab data and competitive landscapes.
Nov 2021 - Feb 2023
Research Associate
- Research:Project I: Elucidation of mechanisms that confer taxane resistance in gastric cancer.This project involves characterizing the role of a microtubule binding protein CLIP170 in conferring resistance to taxanes.
- Multicenter, Randomized Phase II study evaluating Pembrolizumab in combination with chemotherapy and chemoradiation in locally advanced esophageal adenocarcinoma in collaboration with Merck & Co Pharmaceuticals.
- Phase II study of short course FOLFOX chemotherapy with either Nivolumab or Nivolumab + Radiation in the first line treatment of metastatic or unresectable gastroesophageal cancers in collaboration with Bristol Myers.
- Phase II study of Telomelysin (OBP-301) in combination with pembrolizumab in esophagogastric adenocarcinoma, in collaboration with Oncolys Biopharma.
- Phase II clinical trials to investigate effectiveness of cabazitaxel (semi-synthetic drug) in gastric cancer patients in collaboration with Sanofi Pharmaceuticals. - Co-authored Institutional Review Board (IRB).
Sep 2017 - Nov 2021
Postdoctoral Fellow
Sep 2013 - Sep 2017
Volunteer Consultant
The Solution Lab, Inc.
- Identified technologies to increase process efficiencies at various levels of pharmaceutical manufacturing and supply chain for one of the top-five pharmaceutical companies.
- Performed primary and secondary research and developed strategies and timelines for implementation over the next 20 years.
- Client Interaction: Interacted directly with the senior management to present findings and discuss potential implications.
- Quantitative skills: Build incidence driven revenue model for one of the pipeline drugs, currently in Phase I clinical trial.
Jan 2014 - May 2014
Graduate Research Assistant ( Ph.D.)
- Pioneered a new field of cancer research called ‘Mitochondrial epigenetics’.- Thesis title: - ‘Elucidation of mechanisms generating 5-hydroxymethylcytosine (5hmC) in mammalian mitochondria'.- Grants: Co-authored grants and secured peer-reviewed funding from the National Science Foundation of $390K over 3 years.- Mentored 4 graduate students, 2.
Aug 2007 - May 2013
Master Of Science
Jun 2005 - May 2007
Bachelor Of Science
University Of Mumbai
Jun 2002 - Apr 2005
3 education records
Prashant Thakkar, Ph.D. education
Doctor Of Philosophy (Ph.D.), Microbiology And Immunology
Virginia Commonwealth University School Of Medicine
Master Of Science (M.Sc.), Biochemistry
Savitribai Phule Pune University
Bachelor Of Science (B.Sc.), Chemistry - Vocational Biotechnology
University Of Mumbai
FAQ
Frequently asked questions about Prashant Thakkar, Ph.D.
Quick answers generated from the profile data available on this page.
What company does Prashant Thakkar, Ph.D. work for?
Prashant Thakkar, Ph.D. works for Daiichi Sankyo.
What is Prashant Thakkar, Ph.D.'s role at Daiichi Sankyo?
Prashant Thakkar, Ph.D. is listed as Associate Director, Medical Intelligence, Global Oncology Medical Affairs at Daiichi Sankyo.
Where is Prashant Thakkar, Ph.D. based?
Prashant Thakkar, Ph.D. is based in New York City Metropolitan Area, United States, United States while working with Daiichi Sankyo.
What companies has Prashant Thakkar, Ph.D. worked for?
Prashant Thakkar, Ph.D. has worked for Daiichi Sankyo, Agenus, Weill Cornell Medical College, The Solution Lab, Inc., and Virginia Commonwealth University.
How can I contact Prashant Thakkar, Ph.D.?
You can use AeroLeads to view verified contact signals for Prashant Thakkar, Ph.D. at Daiichi Sankyo, including work email, phone, and LinkedIn data when available.
What schools did Prashant Thakkar, Ph.D. attend?
Prashant Thakkar, Ph.D. holds Doctor Of Philosophy (Ph.D.), Microbiology And Immunology from Virginia Commonwealth University School Of Medicine.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial